152 Shares in STERIS plc (NYSE:STE) Bought by Human Investing LLC

Human Investing LLC purchased a new stake in STERIS plc (NYSE:STE) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 152 shares of the medical equipment provider’s stock, valued at approximately $31,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in STE. Exchange Traded Concepts LLC acquired a new stake in shares of STERIS during the 3rd quarter worth approximately $150,000. Creative Planning grew its position in STERIS by 1.4% during the third quarter. Creative Planning now owns 9,019 shares of the medical equipment provider’s stock valued at $2,187,000 after buying an additional 126 shares during the period. Vontobel Holding Ltd. increased its holdings in STERIS by 8.9% in the third quarter. Vontobel Holding Ltd. now owns 2,011 shares of the medical equipment provider’s stock valued at $488,000 after buying an additional 164 shares in the last quarter. Bleakley Financial Group LLC raised its position in shares of STERIS by 8.7% in the third quarter. Bleakley Financial Group LLC now owns 1,680 shares of the medical equipment provider’s stock worth $407,000 after acquiring an additional 134 shares during the period. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in shares of STERIS by 19.1% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 11,046 shares of the medical equipment provider’s stock worth $2,679,000 after acquiring an additional 1,774 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Stock Up 0.1 %

NYSE STE opened at $219.54 on Tuesday. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.55 and a current ratio of 2.13. The business has a fifty day moving average price of $213.03 and a 200 day moving average price of $223.83. The company has a market cap of $21.67 billion, a P/E ratio of 46.61 and a beta of 0.84.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Research analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be given a $0.57 dividend. The ex-dividend date is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.04%. STERIS’s dividend payout ratio (DPR) is presently 48.41%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on STE. StockNews.com cut STERIS from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research note on Friday, November 8th. Piper Sandler boosted their price target on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a report on Thursday, February 6th. Finally, Stephens reiterated an “overweight” rating and issued a $240.00 target price on shares of STERIS in a research report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, STERIS has an average rating of “Moderate Buy” and a consensus target price of $258.75.

Insider Activity at STERIS

In other STERIS news, SVP Cary L. Majors sold 1,682 shares of the company’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $217.32, for a total value of $365,532.24. Following the completion of the sale, the senior vice president now directly owns 11,372 shares in the company, valued at $2,471,363.04. This represents a 12.88 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.14% of the company’s stock.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.